Characterisation and optimisation of diclofenac sodium orodispersible thin film formulation

Research output: Contribution to journalArticle

Abstract

Oral Thin Film (OTF) is a newly emerging drug delivery system which has many benefits for patients. Although there has been some formulation of OTF products, these have mainly been as confectionary or dental health products. The most significant benefit of this dosage format will only be realised once more pharmaceutical products become available. Within this paper, OTF strips containing Diclofenac Sodium were prepared using the solvent casting method and then characterised to ensure the method could conform to acceptable levels of uniformity, the mean (SD) diclofenac sodium content was 25.43 (1.39) mg, range 22.84–27.44 mg. Bioburden was tested against coliforms, yeasts and moulds and all results were confirmed to be <10 CFU/g, also similar dissolution profile when compared to a commercial product to ensure biowaiver. An acceptable level of uniformity of mass was produced. K-F titration was employed to reduce the water content of the strips and it was found to be acceptable, this represented a level of water which would not be viable for microbial growth. The technique employed here in the production of OTF resulted in high quality products and amenability to being up scaled. Furthermore, the characterisation method was also sufficient to assess the quality of the products and may be used for future analysis of OTF pharmaceuticals.

LanguageEnglish
Pages43-46
Number of pages4
JournalInternational Journal of Pharmaceutics
Volume561
Early online date14 Feb 2019
DOIs
Publication statusPublished - 20 Apr 2019

Fingerprint

Diclofenac
Water
Drug Delivery Systems
Pharmaceutical Preparations
Tooth
Fungi
Yeasts
Health
Growth

Keywords

  • oral thin film
  • drug delivery
  • diclofenac sodium
  • solvent casting method

Cite this

@article{a302db695c264c8aa394f162bb158dbc,
title = "Characterisation and optimisation of diclofenac sodium orodispersible thin film formulation",
abstract = "Oral Thin Film (OTF) is a newly emerging drug delivery system which has many benefits for patients. Although there has been some formulation of OTF products, these have mainly been as confectionary or dental health products. The most significant benefit of this dosage format will only be realised once more pharmaceutical products become available. Within this paper, OTF strips containing Diclofenac Sodium were prepared using the solvent casting method and then characterised to ensure the method could conform to acceptable levels of uniformity, the mean (SD) diclofenac sodium content was 25.43 (1.39) mg, range 22.84–27.44 mg. Bioburden was tested against coliforms, yeasts and moulds and all results were confirmed to be <10 CFU/g, also similar dissolution profile when compared to a commercial product to ensure biowaiver. An acceptable level of uniformity of mass was produced. K-F titration was employed to reduce the water content of the strips and it was found to be acceptable, this represented a level of water which would not be viable for microbial growth. The technique employed here in the production of OTF resulted in high quality products and amenability to being up scaled. Furthermore, the characterisation method was also sufficient to assess the quality of the products and may be used for future analysis of OTF pharmaceuticals.",
keywords = "oral thin film, drug delivery, diclofenac sodium, solvent casting method",
author = "Ibrahim Khadra and Obeid, {Mohammad A.} and Claire Dunn and Stewart Watts and Gavin Halbert and Steven Ford and Alexander Mullen",
year = "2019",
month = "4",
day = "20",
doi = "10.1016/j.ijpharm.2019.01.064",
language = "English",
volume = "561",
pages = "43--46",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",

}

TY - JOUR

T1 - Characterisation and optimisation of diclofenac sodium orodispersible thin film formulation

AU - Khadra, Ibrahim

AU - Obeid, Mohammad A.

AU - Dunn, Claire

AU - Watts, Stewart

AU - Halbert, Gavin

AU - Ford, Steven

AU - Mullen, Alexander

PY - 2019/4/20

Y1 - 2019/4/20

N2 - Oral Thin Film (OTF) is a newly emerging drug delivery system which has many benefits for patients. Although there has been some formulation of OTF products, these have mainly been as confectionary or dental health products. The most significant benefit of this dosage format will only be realised once more pharmaceutical products become available. Within this paper, OTF strips containing Diclofenac Sodium were prepared using the solvent casting method and then characterised to ensure the method could conform to acceptable levels of uniformity, the mean (SD) diclofenac sodium content was 25.43 (1.39) mg, range 22.84–27.44 mg. Bioburden was tested against coliforms, yeasts and moulds and all results were confirmed to be <10 CFU/g, also similar dissolution profile when compared to a commercial product to ensure biowaiver. An acceptable level of uniformity of mass was produced. K-F titration was employed to reduce the water content of the strips and it was found to be acceptable, this represented a level of water which would not be viable for microbial growth. The technique employed here in the production of OTF resulted in high quality products and amenability to being up scaled. Furthermore, the characterisation method was also sufficient to assess the quality of the products and may be used for future analysis of OTF pharmaceuticals.

AB - Oral Thin Film (OTF) is a newly emerging drug delivery system which has many benefits for patients. Although there has been some formulation of OTF products, these have mainly been as confectionary or dental health products. The most significant benefit of this dosage format will only be realised once more pharmaceutical products become available. Within this paper, OTF strips containing Diclofenac Sodium were prepared using the solvent casting method and then characterised to ensure the method could conform to acceptable levels of uniformity, the mean (SD) diclofenac sodium content was 25.43 (1.39) mg, range 22.84–27.44 mg. Bioburden was tested against coliforms, yeasts and moulds and all results were confirmed to be <10 CFU/g, also similar dissolution profile when compared to a commercial product to ensure biowaiver. An acceptable level of uniformity of mass was produced. K-F titration was employed to reduce the water content of the strips and it was found to be acceptable, this represented a level of water which would not be viable for microbial growth. The technique employed here in the production of OTF resulted in high quality products and amenability to being up scaled. Furthermore, the characterisation method was also sufficient to assess the quality of the products and may be used for future analysis of OTF pharmaceuticals.

KW - oral thin film

KW - drug delivery

KW - diclofenac sodium

KW - solvent casting method

UR - https://www.sciencedirect.com/journal/international-journal-of-pharmaceutics

U2 - 10.1016/j.ijpharm.2019.01.064

DO - 10.1016/j.ijpharm.2019.01.064

M3 - Article

VL - 561

SP - 43

EP - 46

JO - International Journal of Pharmaceutics

T2 - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

ER -